Patent Assignment
Reel/Frame 059511/0681
Merger
Recorded: 2022-04-06
Pages: 5
Assignor
VALO EARLY DISCOVERY, INC.
Executed: 2020-09-11
Assignee
VALO HEALTH, INC.
399 BOYLSTON STREET, SUITE 505, BOSTON, MASSACHUSETTS, 02116
Covered Property
(1)
3-Aryl-4-Amido-Bicyclic [4,5,0] Hydroxamic Acids as Hdac Inhibitors
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 6, 2022
From: ZHENG, XIAOZHANG; NG, PUI YEE; HAN, BINGSONG; THOMASON, JENNIFER R.
To: FORMA THERAPEUTICS, INC.
Reel/Frame 059511/0634 →
Assignment of Assignor's Interest
Apr 6, 2022
From: FORMA THERAPEUTICS, INC.
To: INTEGRAL EARLY DISCOVERY, INC.
Reel/Frame 059614/0708 →
Change of Name
Apr 6, 2022
From: INTEGRAL EARLY DISCOVERY, INC.
To: VALO EARLY DISCOVERY, INC.
Reel/Frame 059614/0768 →
Security Interest
Jul 6, 2023
From: VALO HEALTH, LLC; VALO HEALTH, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
Reel/Frame 064207/0957 →
Release of Security Interest
Oct 17, 2023
From: FIRST-CITIZENS BANK & TRUST COMPANY, AS AGENT
To: VALO HEALTH, INC.; VALO HEALTH, LLC
Reel/Frame 065255/0660 →